Lv41
610 积分 2021-04-27 加入
A head-to-head comparison of TNF-α inhibitors as the first biologic treatment of rheumatoid arthritis
9天前
已完结
POS0672 A HEAD-TO-HEAD COMPARISON OF TNF-Α INHIBITORS AS THE FIRST BIOLOGIC TREATMENT FOR RHEUMATOID ARTHRITIS
9天前
已关闭
TNF blockade in the treatment of rheumatoid arthritis: infliximab versus etanercept
9天前
已完结
New biologic therapeutics for ulcerative colitis and Crohn's disease
15天前
已完结
Insights into the biology and therapeutic implications of TNF and regulatory T cells
15天前
已完结
AB0482 The cytotoxic effects of certolizumab pegol and golimumab mediated by transmembrane tumor necrosis factor α
17天前
已完结
Mechanism of action of certolizumab pegol (CDP870): In vitro comparison with other anti-tumor necrosis factor α agents
17天前
已完结
Differences in binding and effector functions between classes of TNF antagonists
17天前
已完结
PD-1–targeted cis-delivery of an IL-2 variant induces a multifaceted antitumoral T cell response in human lung cancer
22天前
已完结
Tumor necrosis factor antagonist mechanisms of action: A comprehensive review
1个月前
已完结
皖公网安备34019202002308
